Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a new revision label (v3.5.5) replacing the previous v3.5.4, indicating a minor site update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision label v3.5.3, indicating a new version of the page or its underlying platform.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s UI/release revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without changing the study record content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Naples, Italy (80131) to the study locations and updated the page revision to v3.5.0; Napoli, Italy (80131) was removed.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No changes to study data or essential content are apparent on the page.SummaryDifference0.0%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.